Literature DB >> 21571086

Misfolded protein aggregates: mechanisms, structures and potential for disease transmission.

Ines Moreno-Gonzalez1, Claudio Soto.   

Abstract

Some of the most prevalent human degenerative diseases appear as a result of the misfolding and aggregation of proteins. Compelling evidence suggest that misfolded protein aggregates play an important role in cell dysfunction and tissue damage, leading to the disease. Prion protein (Prion diseases), amyloid-beta (Alzheimer's disease), alpha-synuclein (Parkinson's disease), Huntingtin (Huntington's disease), serum amyloid A (AA amyloidosis) and islet amyloid polypeptide (type 2 diabetes) are some of the proteins that trigger disease when they get misfolded. The recent understanding of the crucial role of misfolded proteins as well as the structural requirements and mechanism of protein misfolding have raised the possibility that these diseases may be transmissible by self-propagation of the protein misfolding process in a similar way as the infamous prions transmit prion diseases. Future research in this field should aim to clarify this possibility and translate the knowledge of the basic disease mechanisms into development of novel strategies for early diagnosis and efficient treatment.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21571086      PMCID: PMC3175247          DOI: 10.1016/j.semcdb.2011.04.002

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  85 in total

1.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

Authors:  D M Walsh; D M Hartley; Y Kusumoto; Y Fezoui; M M Condron; A Lomakin; G B Benedek; D J Selkoe; D B Teplow
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

Review 2.  Protein misfolding and disease; protein refolding and therapy.

Authors:  C Soto
Journal:  FEBS Lett       Date:  2001-06-08       Impact factor: 4.124

3.  Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington's disease.

Authors:  Andreas Weiss; Dorothée Abramowski; Miriam Bibel; Ruth Bodner; Vanita Chopra; Marian DiFiglia; Jonathan Fox; Kimberly Kegel; Corinna Klein; Stephan Grueninger; Steven Hersch; David Housman; Etienne Régulier; H Diana Rosas; Muriel Stefani; Scott Zeitlin; Graeme Bilbe; Paolo Paganetti
Journal:  Anal Biochem       Date:  2009-08-06       Impact factor: 3.365

4.  Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.

Authors:  Omar M A El-Agnaf; Sultan A Salem; Katerina E Paleologou; Leanne J Cooper; Nigel J Fullwood; Mark J Gibson; Martin D Curran; Jennifer A Court; David M A Mann; Shu-ichi Ikeda; Mark R Cookson; John Hardy; David Allsop
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

5.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

Review 6.  A beta oligomers - a decade of discovery.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  J Neurochem       Date:  2007-02-05       Impact factor: 5.372

Review 7.  Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.

Authors:  Charles G Glabe
Journal:  Neurobiol Aging       Date:  2006-02-14       Impact factor: 4.673

Review 8.  Tunnelling nanotubes: a highway for prion spreading?

Authors:  Karine Gousset; Chiara Zurzolo
Journal:  Prion       Date:  2009-04-01       Impact factor: 3.931

Review 9.  Protein misfolding and neurodegeneration.

Authors:  Claudio Soto; Lisbell D Estrada
Journal:  Arch Neurol       Date:  2008-02

10.  Paracrine diffusion of PrP(C) and propagation of prion infectivity by plasma membrane-derived microvesicles.

Authors:  Vincenzo Mattei; Maria Grazia Barenco; Vincenzo Tasciotti; Tina Garofalo; Agostina Longo; Klaus Boller; Johannes Löwer; Roberta Misasi; Fabio Montrasio; Maurizio Sorice
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

View more
  71 in total

1.  Crystallization and preliminary X-ray crystallographic analysis of the curli transporter CsgG.

Authors:  Parveen Goyal; Nani Van Gerven; Wim Jonckheere; Han Remaut
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-11-28

2.  Loss-of-function mutations in co-chaperone BAG3 destabilize small HSPs and cause cardiomyopathy.

Authors:  Xi Fang; Julius Bogomolovas; Tongbin Wu; Wei Zhang; Canzhao Liu; Jennifer Veevers; Matthew J Stroud; Zhiyuan Zhang; Xiaolong Ma; Yongxin Mu; Dieu-Hung Lao; Nancy D Dalton; Yusu Gu; Celine Wang; Michael Wang; Yan Liang; Stephan Lange; Kunfu Ouyang; Kirk L Peterson; Sylvia M Evans; Ju Chen
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

Review 3.  Type 2 diabetes as a protein misfolding disease.

Authors:  Abhisek Mukherjee; Diego Morales-Scheihing; Peter C Butler; Claudio Soto
Journal:  Trends Mol Med       Date:  2015-05-18       Impact factor: 11.951

4.  Structure of the nonameric bacterial amyloid secretion channel.

Authors:  Baohua Cao; Yan Zhao; Yongjun Kou; Dongchun Ni; Xuejun Cai Zhang; Yihua Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

5.  Meal frequency and timing in health and disease.

Authors:  Mark P Mattson; David B Allison; Luigi Fontana; Michelle Harvie; Valter D Longo; Willy J Malaisse; Michael Mosley; Lucia Notterpek; Eric Ravussin; Frank A J L Scheer; Thomas N Seyfried; Krista A Varady; Satchidananda Panda
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

6.  Role of domain interactions in the aggregation of full-length immunoglobulin light chains.

Authors:  Enrico Rennella; Gareth J Morgan; Jeffery W Kelly; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-31       Impact factor: 11.205

Review 7.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.590

Review 8.  Inhibition of protein misfolding and aggregation by natural phenolic compounds.

Authors:  Zohra Dhouafli; Karina Cuanalo-Contreras; El Akrem Hayouni; Charles E Mays; Claudio Soto; Ines Moreno-Gonzalez
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

9.  Computational modeling of the relationship between amyloid and disease.

Authors:  Damien Hall; Herman Edskes
Journal:  Biophys Rev       Date:  2012-09

10.  Plasma prion protein concentration and progression of Alzheimer disease.

Authors:  Christian Schmidt; Harry Becker; Christoph Peter; Katharina Lange; Tim Friede; Inga Zerr
Journal:  Prion       Date:  2014-02-18       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.